Systemic Delivery, Local Activity: Bonum is focused on a proven technology that utilizes regulation to create targeted, highly active, and less toxic medicines. Connect with John Mulligan, Ph.D., Diane Hollenbaugh, Ph.D., Justin Killebrew, Ph.D., & Shannon Okada at #AACR24 as they share preclinical data on our lead program, cLAG3-IL2.
Bonum Therapeutics’ Post
More Relevant Posts
-
Please consider joining the webinar to learn about the importance of genetic evidence to improve productivity in drug development.
The ASA SSGG Member Engagement Committee presents a webinar on "The importance of genetic evidence to improve productivity in drug discovery and development". Our distinguished speaker for this event is Dr. Matthew Nelson. I will co-host this event with Dr. Judong Shen from Merck. 3/25/2024 | 1:00 - 2:00 PM (Eastern) / 10:00 - 11:00 AM (Pacific) Registration (free but required): https://lnkd.in/erFRJX4R
To view or add a comment, sign in
-
-
It's time for another #Type1DiabetesGrandChallenge #research project spotlight! 🔬🌟 Dr Danijela Tatovic will run small clinical trial testing whether combining two different drugs can help protect surviving beta cells and delay progression of #Type1Diabetes. The drugs are immunotherapies called abatacept and IL-2, which are both licensed to treat other autoimmune conditions. Find out more 👉 https://orlo.uk/NsKl2
To view or add a comment, sign in
-
-
Great webinar! Check it out!
The ASA SSGG Member Engagement Committee presents a webinar on "The importance of genetic evidence to improve productivity in drug discovery and development". Our distinguished speaker for this event is Dr. Matthew Nelson. I will co-host this event with Dr. Judong Shen from Merck. 3/25/2024 | 1:00 - 2:00 PM (Eastern) / 10:00 - 11:00 AM (Pacific) Registration (free but required): https://lnkd.in/erFRJX4R
To view or add a comment, sign in
-
-
Consider joining this upcoming workshop on Monday on how genetic evidence can improve and enhance drug discovery. Thanks to ASA section on genetics for organizing.
The ASA SSGG Member Engagement Committee presents a webinar on "The importance of genetic evidence to improve productivity in drug discovery and development". Our distinguished speaker for this event is Dr. Matthew Nelson. I will co-host this event with Dr. Judong Shen from Merck. 3/25/2024 | 1:00 - 2:00 PM (Eastern) / 10:00 - 11:00 AM (Pacific) Registration (free but required): https://lnkd.in/erFRJX4R
To view or add a comment, sign in
-
-
Last Chance: .PermeabilitySeries Webinar Tomorrow! 🚨 Don't miss out on our exclusive .PermeabilitySeries webinar, "Drug delivery to the brain: In situ gelling formulation enhances carbamazepine diffusion through nasal mucosa models with mucin." with ELISA CORAZZA. Elisa's research with angela abruzzo, Massimiliano Pio di Cagno, Annette Bauer-Brandl and Barbara Luppi focuses on optimizing a thermosensitive in situ gelling formulation to enhance intranasal and nose-to-brain delivery of the antiepileptic drug carbamazepine (CBZ). Discover the preliminary findings and innovative approaches that promise to revolutionize drug delivery to the brain. 📅 Save the Date: December 6th, 2023, at 3:00 pm CET. 🔗 Register for Free: https://lnkd.in/epAnD8iB Act fast to explore the latest in drug permeability research. Join us and stay tuned for more updates from PHABIOC! #PermeabilitySeries #Webinar #PHABIOC
To view or add a comment, sign in
-
-
🧬 Exciting Innovations in Drug Development! 🌟 Small molecules and antibodies have long been primary channels of drug development, but there's another rising player on the scene - Oligonucleotides (OGNTs). These short DNA/RNA strands are revolutionizing personalized medicine, offering precise disease-targeting at the source. 💡 Why are OGNTs a game-changer? 1. Drugging the "undruggable": OGNTs open doors to tackle previously untreatable diseases. 2. Accelerating drug development: Speeding up the process, saving lives. 3. Driving technological advancements: Paving the way for cutting-edge therapies. The global market is soaring, projected to hit $5.7 trillion by 2030! 📈 Be part of this healthcare revolution. Learn more in our White Paper. Download it here: https://lnkd.in/erny9J3G #DrugDiscovery #PersonalizedMedicine #Oligonucleotides #HealthcareInnovation #DrugDevelopment
To view or add a comment, sign in
-
-
R&D Innovation | Precision Medicine | Drug Development | Ex-vivo Pharmacology | Head Of BD @ Inoviem Scientific
what if we could assess, directly on human native diseased tissues, whether a drug is interacting with its target and at the same time identify the triggered pathway and clinical Mode of Action? Well, Nematic Protein Organisation Technique (NPOT) does exactly this. How? Take a look at the video here👇 https://lnkd.in/dA3HqYJh
The future of drug development is NPOT®
https://www.youtube.com/
To view or add a comment, sign in
-
I love this explainer of how RNA drugs work. It's ridiculously simple. #omicsnews #precisionmedicine #RNA #bitoechnews #pharmanews #proteomics #biomarkers #healthcareinnovation
The tech that Rohan Hockings is explaining here is so cutting edge, it hasn't been proved yet to work in humans as a medicine -- at least to the satisfaction of the drug regulators. However, his company, PYC Therapeutics (ASX: PYC), has a secret weapon up their sleeve that gives them an extra edge when it comes to kidney disease. Tune in when we launch in August to find out what that very science fiction tool is. NWR Communications Matthew Wright
To view or add a comment, sign in
-
If you're looking to harness the benefits of iPSC technology, we're making it simpler and cheaper to get started. At the start of this year, we pledged to support the growing iPSC market and, unlike other suppliers, we've made affordability a priority with: • Our 2024 price freeze • A range of promotions and custom bulk/academic pricing • Capabilities across the spectrum of iPSC users, from first-timers to those looking to build large systems and scale up Ultimately we're all progressing to the same goal: building better human disease models to improve the lives of patients worldwide. We'll continue to lead the way in supporting the iPSC market and offering our expertise to drug discovery researchers. If you'd like to find out more about our 2024 Pricing and Promotions click here: https://hubs.la/Q02qxY_W0 #iPSCs #StemCells #DrugDiscovery #NeurodegenerativeDisease #biopharma
To view or add a comment, sign in
-
More from this author
-
The Business of Biotech Highlights Bonum CEO John Mulligan & CBO Neela Patel
Bonum Therapeutics 7mo -
A BD Checklist: Best Practices for Partnering with Pharma - by Neela Patel
Bonum Therapeutics 9mo -
Developing the Next Generation of Targeted, Conditionally Active Cytokine Therapeutics - by Justin Killebrew
Bonum Therapeutics 1y